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Abstract 
A novel MEMS based drug delivery device has been developed, consisting of an array of metallic contacts. The 
meander structured device created a uniform electric field which stimulates drug releases. An electro-active hydrogel 
based polymer matrix responds to an electrical stimulus and shrinks or de-swells on application of an electric field 
from the fabricated device. Different drug candidates can be encapsulated within the polymer matrix. The de-swelling 
of the polymer enables the encapsulated drug to be released from the matrix. The gel is able to recover its original 
size once electric stimulation has been stopped. By controlling the voltage and time, the drug release rate and dose 
can be precisely controlled. Controlled drug delivery devices may be integrated with sensor technology in combined 
diagnostic / therapeutic point of care devices. 
 
© 2011 Published by Elsevier Ltd. 
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1. Introduction 
Techniques for controlled and targeted drug delivery have drawn increasing attention in both research 
and clinical applications over the last few decades [1-4].  To achieve responsive, controllable delivery of 
active compounds is a major challenge. Two different methodologies have been broadly investigated: 
drug release payload after a certain time delay or pulsed release in pre-determined sequences [4, 5]. 
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Electro-responsive drug delivery, with microfabricated membrane structures or certain hydrogels, can be 
used to administer time-legged or pulsed drug release [6-10]. Using hydrogels in three-dimensional high-
molecular weight networks, electro-responsive controlled drug delivery, offers prolonged and better 
control of drug administration, maintaining the drug in the desired therapeutic range with just a single 
dose, and localized delivery of the drug to a particular organs, which are important in a wide variety of 
applications in medical and pharmaceutical fields [6-8].  
In this paper, a novel MEMS based drug delivery device, consisting of an array of metallic contacts, is 
presented. The device creates a uniform electric field which stimulates drug release. Based on an electro-
active hydrogel based polymer matrix, the delivery microsystem responds to an electrical stimulus and the 
shrinking or de-swelling of the polymer matrix enables the encapsulated drug to be released. 
2. Device Design and Fabrication 
Metallic meander tracks were designed in widths of 3Pm and 10Pm. The fabricated devices, shown in 
Fig. 1, have footprints of 240Pm×250Pm and 700Pm×700Pm, respectively. The 100nm thick metallic 
contacts were produced by sputtering titanium/platinum metallic contact layers, and patterned using an 
ion beam etching process. An annealing process for 5 hours at 350°C was performed to have reliable 
functional devices, which helped to secure the electrical characteristics of the deposited and patterned 
metallic meander tracks. Both thermal and electric field properties of the device have been simulated 
using finite element methods. The simulation result in Fig. 2 (a) shows that a uniform electric potential 
was created along the metallic meander tracks, which resulted in a uniform electric field along the 
meander metallic contacts (except the end corners) shown in Fig. 2 (b). In simulations, a voltage of 1.67V 
was applied to 3-unit of meander metallic contact structure equivalent to 20V on the actual fabricated 
structure of 36 meander units (Fig. 1(b)). The thermal properties of the meander structures under a 
constant DC bias have been measured using a probe station coupled to a HP 4142b electrical analyzer 
(Fig. 3) assisted with a thermal couple meter. The device temperatures under different DC conditions are 
shown in Fig 4. These results show that fabricated devices operate at normal body temperature (37°C) 
when a DC bias of 20V is applied to the meander structured device. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2. FEM simulation results of (a) electric 
potential and (b) electric field vector summation in 
a 3-unit metallic meander structure. 
 
                     (a)                                              (b) 
Fig. 1. Fabricated drug delivery devices with meander 
metallic structures in track width of (a) 3Pm, and (b) 10Pm. 
Fig. 3. Schematic set up for thermal property tests. 
 
Fig. 4. Thermal property of fabricated 
devices under different DC voltages. 
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3. Drug Delivery Experiments   
A schematic of the electric field responsive controlled drug delivery is shown in Fig. 5. Hematoxylin 
was selected as model of hydrophilic drug. Hematoxylin is a chromophore with a maximum absorbance 
at 560nm, therefore release from the hydrogel polymer matrix can be easily monitored using UV-visible 
spectroscopy. The amount of hematoxylin released in the media can be quantified using the calibration 
curve established at high and low concentrations. Shown in Fig. 6, reference absorption spectra at 560nm 
of the polymer preloaded dye in deionized water at high concentrations (0 to 80mg/l) and low 
concentrations (0 to 1.6mg/l) were pre-measured using a LAMBDA 750 spectrophotometer (PerkinElmer 
Inc.). A 1Pl volume of the pre-polymerised solution, containing methacrylic acid as monomer, N,N’-
methylene bisacrylamide as cross-linker and potassium persulfate as initiator, was dropped onto a 
700Pm×700Pm device and polymerized by heating the device up to 60°C for a few minutes. 
Hematoxylin was loaded into the polymer matrix by swelling of the dry hydrogel. This was performed by 
immersing the device in hematoxylin solution at high concentration for 30 minutes. A 20V DC voltage 
was used to trigger drug release from the hydrogel. The release of hematoxylin was monitored by taking 
3ml aliquots from the media each time while the voltage was applied on and off. The release profile (Fig. 
7) show that concentration of hematoxylin dye in the solution increased upon exposure to the uniform 
electric field created by the meander metallic stimulating dye release into the solution. The amount of dye 
released from the polymer matrix was quantified according to the reference curve (Fig. 6). When the 
applied voltage was stopped, the released of hematoxylin was significantly reduced, leading to a pulsatile 
hematoxylin release profile. Alternatively, small volumes of the drug may be continuously delivered to 
maintain the optimum therapeutic dose for the patient in conjunction with a diagnostic device.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Schematic of polymer de-swelling drug delivery device due to electronic field. 
 
Fig. 6. Results of reference light absorption tests at 560nm 
using LAMBDA 750 spectrophotometers. 
Fig. 7. Hematoxylin dye release VS time in response 
to applied voltage. 
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4. Conclusions  
A novel MEMS based drug delivery microsystem has been designed and successfully fabricated. The 
device consists of an array of metallic contacts, able to create to uniform electric field. A hydrogel 
polymer matrix loaded with hematoxylin dye as model of hydrophilic drug has been studied. The delivery 
microsystem operated at normal body temperature (37°C) under an applied voltage of 20 V. The release 
rate and dose was accurately controlled. The polymer responds to the electrical stimulus by shrinking and 
releases the hematoxylin dye into solution. Release of hematoxylin in the media was monitored using 
ultraviolet-visible spectrophotometry at the Ȝmax of the dye (560nm). 
Different drug candidates can be encapsulated within the hydrogel polymer matrix. The de-swelling of 
the polymer upon exposure to the applied electric field enables the encapsulated drug to be released from 
the matrix. Control of the applied voltage can be used to achieve pulsatile drug delivery. Alternatively, 
small volumes of the drug may be continuously delivered to maintain the optimum therapeutic dose for 
the patient. 
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